Charles Schwab’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Buy
24,270
+2,863
+13% +$45.5K ﹤0.01% 3301
2026
Q1
$345K Sell
21,407
-2,866
-12% -$49.9K ﹤0.01% 3212
2025
Q4
$448K Buy
24,273
+4,915
+25% +$89.8K ﹤0.01% 3190
2025
Q3
$349K Hold
19,358
﹤0.01% 3270
2025
Q2
$375K Sell
19,358
-3,110
-14% -$58.6K ﹤0.01% 3239
2025
Q1
$349K Buy
22,468
+3,343
+17% +$59.8K ﹤0.01% 3169
2024
Q4
$340K Hold
19,125
﹤0.01% 3248
2024
Q3
$345K Sell
19,125
-1,603
-8% -$29.3K ﹤0.01% 3255
2024
Q2
$322K Buy
+20,728
New +$343K ﹤0.01% 3350

Other funds holding MDWD

Charles Schwab's MDWD Position: Q2 2026 in Review

Charles Schwab increased its MediWound (MDWD) stake by 13% in Q2 2026, buying an estimated $45.5K and bringing the position to 24,270 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #3301.

Charles Schwab first reported a position in MDWD in Q2 2024 and has held it in 9 quarters since. The position peaked at $448K in Q4 2025. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • Charles Schwab held 24,270 shares of MediWound worth $357K as of Q2 2026.
  • Charles Schwab bought 2,863 MediWound shares in Q2 2026, an estimated $45.5K.
  • MediWound made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3301 holding.
  • Charles Schwab first reported a position in MediWound in Q2 2024 and has held it in 9 quarters since.
  • Charles Schwab's MediWound position peaked at $448K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.